Alendronate blocks metalloproteinase secretion and bone collagen I release by PC-3 ML cells in SCID mice

This publication has 46 references indexed in Scilit:

• Bisphosphonates: mechanisms of action.
  Journal of Clinical Investigation, 1996
• New bisphosphonates in the treatment of bone metastases
  Cancer, 1993
• Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue.
  1993
• Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression.
  1991
• Inhibition by a new bisphosphonate (AHBuBP) of bone resorption induced by the MBT-2 tumor of mice
  Cancer, 1991
• Effect of etidronate disodium on the development of bone lesions in an animal model of bone metastasis using the human prostate cancer cell line PC‐3
  The Prostate, 1991
• Human osteoblasts in vitro secrete tissue inhibitor of metalloproteinases and gelatinase but not interstitial collagenase as major cellular products.
  Journal of Clinical Investigation, 1989
• The relationship of collagenolytic activity to stage of human colorectal carcinoma
  International Journal of Cancer, 1987
• Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and biphosphonate treatment
  European Journal of Cancer and Clinical Oncology, 1986
• Mouse osteoblasts synthesize collagenase in response to bone resorbing agents
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1984